Karen Linehan
Director/Board Member at AELIS FARMA
Net worth: 125 696 $ as of 2024-05-30
Karen Linehan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AELIS FARMA | Director/Board Member | 2021-12-31 | - |
| Independent Dir/Board Member | 2021-12-31 | - | |
| CNH INDUSTRIAL N.V. | Director/Board Member | 2022-03-10 | - |
| Independent Dir/Board Member | 2022-03-10 | - | |
Hoechst GmbH
 Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Director/Board Member | - | - |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Director/Board Member | - | - |
Global Antibiotic Research & Development Partnership
 Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Director/Board Member | - | - |
| Georgetown University Law Center | Corporate Officer/Principal | - | - |
Career history of Karen Linehan
Former positions of Karen Linehan
Training of Karen Linehan
| Georgetown University | Graduate Degree |
Statistics
International
| France | 4 |
| United States | 3 |
| Germany | 3 |
Operational
| Director/Board Member | 7 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Communications | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| SANOFI | Health Technology |
| VEON LTD. | Communications |
| AELIS FARMA | Health Technology |
| CNH INDUSTRIAL N.V. | Producer Manufacturing |
| EUROAPI | Health Technology |
| Private companies | 3 |
|---|---|
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Health Technology |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Health Technology |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Health Technology |
- Stock Market
- Insiders
- Karen Linehan
- Experience
